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Background: Inguinal hernia repair is one of the most common operations in general
surgery. The Lichtenstein tension-free operation has become the gold standard in open
inguinal hernia repair. Despite the low recurrence rates, pain and discomfort remain a
problem for a large number of patients. The aim of this study was to compare suture fixa-
tion vs. fibrin sealing by using a new monofilament PTFE mesh, i.e., the Infinit® mesh by
W. L. Gore & Associates.
Methods: This study was designed as a controlled prospective single-center two-cohort
study. A total of 38 patients were enrolled and operated in Lichtenstein technique either
standard suture mesh fixation or fibrin-sealant mesh fixation were used as described in the
TIMELI trial. Primary outcome parameters were postoperative complications with the new
mesh (i.e., seroma, infection), pain, and quality of life evaluated by the VAS and the SF-36
questionnaire. Secondary outcome was recurrence assessed by ultrasound and physical
examination. Follow-up time was 1 year.
Results: Significantly, less postoperative pain was reported in the fibrin-sealant group
compared to the suture group at 6 weeks (P =0.035), 6 months (P =0.023), and 1 year
(P =0.011) postoperatively. Additionally, trends toward a higher postoperative quality of
life, a faster surgical procedure, and a shorter hospital stay were seen in the fibrin-sealant
group.
Conclusion: Fibrin-sealant mesh fixation in Lichtenstein hernioplasty effectively reduces
acute and chronic postoperative pain. Monofilament, macro-porous, knitted PTFE meshes
seem to be a practicable alternative to commonly used polypropylene meshes in open
inguinal hernia repair.
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INTRODUCTION
Inguinal hernia repair is one of the most common surgical oper-
ations in general surgery. In 2010, 19,515 inguinal hernias were
treated in Austria, 17,094 among men and 2,421 among women
(1). Tension-free mesh augmented operation has become the stan-
dard technique in inguinal hernia surgery (2–5). The Lichtenstein
repair utilizing prosthetic meshes is the most commonly used
technique. In the past, clinical trials regarding hernia repair, con-
centrated on the long-term analysis of recurrence rates. More
recently, the focus of several clinical trials has been placed on
aspects of quality of life and chronic pain syndromes (6–10).
Indeed, despite the low recurrence rates [fewer than 5% (4, 11,
12)] of the Lichtenstein open tension-free mesh augmented repair
postoperative pain and chronic postoperative pain syndromes still
remain a problem (13–18). Moreover patients frequently report a
feeling of numbness, stiffness, or foreign body, after implantation
of a commonly used polypropylene mesh. Several studies and
randomized clinical trials indicate that up to 30% of patients
report some form of pain 1 year after Lichtenstein hernia repair
(5, 19). As a result of these findings, numerous studies were
initiated to estimate the ideal material for implantation in the
inguinal region (20–22). There is evidence that reduced weight
macro-porous meshes are associated with more patient comfort,
a better physical function and less pain during activity (6, 20,
21, 23). It was demonstrated that fibrin-sealant mesh fixation is
superior to suture fixation on aspects of quality of life, patient
comfort, postoperative pain, and chronic pain (6, 10, 24–28). In
the past, polytetrafluorethylene (PTFE) meshes were processed
to micro-porous patches. The combination of hydrophobic PTFE
with micro-pores led to frequent mesh graft infections, resulting in
obligatory mesh explanations (22, 29, 30). The new monofilament,
macro-porous, knitted PTFE mesh (Inifnit® mesh; W. L. Gore &
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Associates) used in this study, promised to profit from the advan-
tages of PTFE, such as low foreign body reaction, without having
to deal with the frequent complication of mesh graft infection.
Especially in an experimental study, the advantages of condensed
PTFE meshes in combination of fibrin sealant for fixation could
be demonstrated (31).
MATERIALS AND METHODS
This study was a controlled, unicentric, two-cohort pilot study
at the Department of General, Visceral and Oncological Surgery,
Wilhelminenspital Vienna and designed as a pilot study for a fur-
ther planned randomized controlled trial study. The permission
of the local ethical committee was granted. All patients seen at the
outpatient ward for hernia diseases at the Department of General,
Visceral and Oncologic Surgery, Wilhelminenspital Vienna, with
the diagnosis of a unilateral primary inguinal hernia were consid-
ered for entry into the study. All enrolled patients had to fulfill the
inclusion criteria and had to give informed consent to participate
in this study. Patients were randomized using an online random-
izing tool. Patients eligible for inclusion were aged between 18 and
80 years; had a unilateral primary inguinal hernia; were sched-
uled for elective operation and had the intellectual capacity to
participate in this study. Exclusion criteria were femoral hernias;
recurrent inguinal hernias; American society of Anesthesiologists
(ASA) IV or higher; a poor understanding of the German lan-
guage; non-compliance; incarcerated or strangulated hernias; and
pregnancy. A total of 38 patients with the diagnosis of a uni-
lateral primary inguinal hernia were enrolled, 20 patients were
assigned to the suture group (SUT) and 18 patients were assigned
to the fibrin-sealant-group (FS). In the SUT cohort, the mesh
was fixated only with sutures and in the second cohort the mesh
was fixated with fibrin glue, whereas one suture was allowed to
recreate a new inguinal ring by suturing the two crossed tails of
the mesh lateral to spermatic cord. Originally, it was planned to
enroll a total of 50 patients, 25 patients for each group. How-
ever, W. L. Gore & Associates unexpectedly stopped the sale of
the Infinit mesh, without giving reason. This forced our study
group to stop the patient enrollment with a total of 38 patients,
20 patients in the SUT group, and 18 in the FS group (Table 1).
Patients were allocated to one of the both groups by the study
group. The study group monitored the equality of the two groups
regarding age, sex, pain, hernia size et cetera. Follow-up period was
1 year. We exclusively used the Infinit® mesh, W. L. Gore & Asso-
ciates a monofilament, macro-porous, knitted, middle-weight, and
polytetrafluoroethylene (PTFE) surgical mesh (weight 70 g/m2;
pore size is 2–3 mm and the thickness of the monofilament fibers
is 0.4 mm).
OPERATING PROCEDURES
All operations were performed applying general anesthesia. Thirty
minutes before the end of the operation, 1 g Paracetamol was
administered intravenously to each patient. At the end of the
operation, the OP-site was infiltrated with Naropin. Antibiotic
prophylaxis was sustained by the administration of a single shot
of second, respectively third generation cephalosporines during
the operation. To treat postoperative pain, no NSAIDs or COX-2
inhibitors but paracetamol and tramadol were used.
Table 1 | An overview of patients characteristics and distribution of
different hernia types according to the Aachen classification.
FS group SUT group Total
Patients 18 20 38
Males 16 18 34
Females 2 2 4
Age 47.28±14.93 54.35±16.68 51±16.06
BMI 25.06±4.1 25.88±3.2 25.49±3.63
Aachen classification
L I 0 6 6
L II 8 6 14
L III 4 1 5
M I 4 0 4
M II 0 6 6
Mc I 1 0 1
Mc II 1 1 2
SUTURE FIXATION
All surgeons in the study group adhered to the refined stan-
dard Lichtenstein open tension-free hernioplasty technique as
described by Amid (4).
FIBRIN-SEALANT MESH FIXATION
The skin incision and the preparation of the inguinal region in the
fibrin-sealant group did not differ from that applied in the SUT
group. The preliminary shaping of the mesh was identical to that
described for the suture group. A single absorbable suture was
used in the fibrin-sealant group to narrow the internal inguinal
ring and fixate the two tails of the mesh lateral to the internal
ring (32). However, the mesh was then exclusively fixated with
2 ml of Fibrin glue (500 IU Tissucol® Baxter Healthcare). The fib-
rin glue was prepared according to the manufacture’s instruction,
and applied using the Duploject syringe and a spray head (32).
After the preparation of the inguinal region and correct position-
ing of the mesh the complete prepared Tissucol was placed over
the entire surface of the mesh, using the spray-effect. Subsequent,
the mesh was pressed onto the tissue for 2 min until the polymer-
ization of the glue was completed (32). Closure of the external
oblique aponeurosis and the skin was identically to that applied in
the suture group.
PAIN VAS SCORE
The visual analog scale (VAS) consists of a simple scale with a
length of exactly 100 mm, on which patients were asked to rate
their pain from 0 (completely absence of pain) to 100 (worst
imaginable pain) (33).
All enrolled patients were asked to mark their current sen-
sation of pain on a VAS preoperatively; the first day postop-
eratively; the second day postoperatively; at the day of dis-
charge; 6 weeks postoperatively, 6 months postoperatively, and
1 year postoperatively.
QUALITY OF LIFE – SHORT-FORM 36 QUESTIONNAIRE
The short-form 36 (SF-36) is a short-form health survey with
36 questions. It yields an 8-scale profile of functional health and
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well-being scores. The eight scales are physical functioning (PF),
role-physical (RP), bodily pain (BP), general health (GH), vitality
(VT), social functioning (SF), role-emotional (RE), and mental
health (MH).
These eight scales are additionally summarized psychometri-
cally to two summary measures, physical health (PHS), and mental
health (MHS). The evaluation of the SF-36 survey is performed by
standardized, automatic computer programs. Thus for each scale
and both summary measures, a score from 0 (worst) to 100 (best)
will be generated.
All patients were asked to complete the SF-36 questionnaire
preoperatively, 6 weeks after the operation, 6 months after the
operation, and 1 year after the operation.
STATISTICAL ANALYSIS
All statistical analyses were performed with the SPSS 17 soft-
ware. Primary outcome parameters were pain, quality of life,
and post-OP complications. Secondary outcome parameter was
recurrence.
The mean, SD, median, minimum, maximum, and quartiles
of the VAS and SF-36 scores were calculated per cohort (pre-
operatively, 6 weeks postoperatively and 1 year postoperatively).
An unpaired t -test was performed to investigate the discrepancy
among the two groups (fibrin-sealant mesh fixation versus suture
mesh fixation) regarding the mean difference between the pre- and
6 weeks postoperative, the mean difference between the pre- and
6 months SF-36 scores, as well as the mean difference between the
pre- and 12 months postoperative SF-36 scores for each cohort.
To compare and analyze the kind and frequency of complications,
i.e., seroma or infection, among the two groups (fibrin-sealant
mesh fixation versus suture mesh fixation) all complications were
recorded and described in each group.
Originally, it was intended to include 100 patients (n= 50
per group). Accordingly, the sample size was calculated with
Russ Length’s online sample size calculator (recommended by the
department of medical statistics; Medical University Vienna). A
sample size of 50 individuals was calculated, utilizing an unpaired
t -test. The primary outcome parameter “pain” (evaluated by the
VAS) was considered for the calculations. A two-sided significance
of 0.05 and a power of 0.80 were applied. As the endpoint of the
study was not met, this power analysis was irrelevant. Results of
the patients who could finally be included were tested for normal
distribution and a Kolmogorov–Smirnov test was applied. In this
test, no significance was achieved, thus normal distribution was
assumed.
RESULTS
Because of the premature end of the study, statistical power was
again verified for the obtained set of data.
STUDY POPULATION
A total of 38 patients with the diagnosis of a unilateral pri-
mary inguinal hernia were enrolled in this study, 20 patients were
assigned to the suture group and 18 patients were assigned to the
fibrin-sealant group. The two groups were comparable concerning
all study variables except the mean age; however, the difference of
the age was none significant.
OPERATION TIME
Allover, the mean duration of the surgical procedure was
52± 20.12 min (range 25–123). Within the suture group, the mean
duration of the surgical procedure was 53.3± 24.66 min (range
25–123). Within the fibrin-sealant group, the mean duration of
the surgical procedure was 50.56± 14.06 min (range 35–90).
HOSPITAL STAY
The hospital stay of all enrolled patients revealed a mean of 4 days
(SD 1.09; range 2–7). Twenty patients assigned to the suture group
stayed for a mean of 4.15 days (SD 0.88; range 2–5) and 18 patients
assigned to the fibrin-sealant group stayed for a mean of 3.83 days
(SD 1.3; range 2–7), respectively at the in-patient ward.
COMPLICATIONS
In two patients (5.3%), a partial resection of the iliohypogas-
tric nerve was performed consequently to intra-operative damage
(both were assigned to the fibrin-sealant group). No further
intra-operative complications were reported.
Seven (18.4%) of all patients participating in this study were
suffering from postoperative complications. Six (15.8%) were suf-
fering from a hematoma and one (2.6%) patient was suffering
from a seroma. Within the suture group four (20%) patients were
suffering from a hematoma and none from a seroma; whereas
two (11.1%) patients within the fibrin-sealant group were suf-
fering from a hematoma and one (5.6%) patient from a seroma.
There was no significant difference concerning postoperative sur-
gical complications, between the two groups. None of the patients
suffering from postoperative complications needed any further
clinical treatment.
One recurrent hernia in the fibrin-sealant group was detected
by ultrasound 1 year after the operation. In this patient, the
recurrent hernia was treated by a laparoscopic transabdominal
preperitoneal (TAPP) procedure.
PAIN
Preoperative pain assessed by the VAS, was comparable between
the two groups 25.83± 17.34 (range 0–70) within the suture group
and 24.06± 15.3 (range 0–75) within the fibrin-sealant group.
Early postoperative pain assessed at rest on day 1, day 2, and on
the day of discharge, was not significantly different between the
two groups.
On re-evaluation after 6 weeks, the mean VAS score of
8.61± 10.39 of the patients within the fibrin-sealant group was
significantly lower than the mean VAS score of 19.72± 18.98 of
the patients within the suture group P = 0.035.
On re-evaluation after 6 months, the mean VAS score of
6.82± 9.72 of the patients within the fibrin-sealant group was
significantly lower than the mean VAS score of 17.61± 16.41 of
the patients within the suture group P = 0.023.
At the final assessment after 1 year, the mean VAS score of
5.93± 8.06 of the patients within the fibrin-sealant group was
significantly lower than the mean VAS score of 18.17± 17.52 of
the patients within the suture group P = 0.011.
Additionally, the number of patients suffering from moderate-
severe pain (VAS ≥30) 1 year postoperatively was lower in the
fibrin-sealant group 1/18 (0.55%) versus 5/20 (25%) in the suture
group.
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FIGURE 1 | Change of the mean VAS score within the two groups over time.
The mean VAS scores of both groups decreased rapidly after
the operation and during the hospital stay to a bottom level at the
day of discharge from hospital. On re-evaluation after 6 weeks, the
mean VAS scores of both groups increased from the bottom level
seen at the day of discharge from hospital (see Figure 1). However,
the mean VAS score of the suture group increased to a significant
higher level than the mean VAS score of the fibrin-sealant group.
During the period between the re-evaluation after 6 weeks and the
re-evaluation after 6 months the mean VAS scores of both groups
decreased, whereas the mean VAS score of the fibrin-sealant group
was significantly lower compared to the mean VAS score of the
suture group. During the period between the re-evaluation after
6 months and the final assessment after 1 year, the mean VAS score
of the suture group increased in contrast to the mean VAS score of
the fibrin-sealant group, which decreased during that period, to a
significant lower level compared to the suture group.
QUALITY OF LIFE
In both groups, the mean scores of the PF scale increased con-
stantly during the follow-up period. In the suture group, the mean
score increased from 69.38± 26.15 to 80.08± 24.73 1 year after
the operation and in the fibrin-sealant group the mean scores
increased from 70± 19.93 to 79.53± 21.71 1 year after the oper-
ation. The mean scores of the RP scale was constantly increasing
in the fibrin-sealant group from 55.77± 37.53 to 81.62± 30.78
1 year after the operation, whereas the mean score in suture
group decreased 6 weeks after the operation to a bottom level of
51.18± 42.52. From this bottom level after 6 weeks, the mean score
of the RP scale in the suture group increased to 68.68± 39.67 1 year
after the operation. In the fibrin-sealant group, the mean score of
the BP scale (Figure 2A) immediately raised from 59.85± 18.77
to 71.21± 25.12 6 weeks after the operation. During the period
from 6 weeks and 6 months postoperatively, the mean score of
the BP scale did not significantly change to 71.10± 25.11. From
the assessment 6 months after the operation, the mean score of
the BP scale in the fibrin-sealant group, raised to 74.60± 21.09
1 year postoperatively. In the suture group, the mean score of
the BP scale immediately felt in contrast to the fibrin-sealant
group, from 66.38± 20.21 to 62.89± 27.75 6 weeks postopera-
tively. From the level at 6 weeks postoperatively, the mean score of
the BP scale raised to 75.09± 24.36, to finally fall to 66.63± 34.59
1 year after the operation. Thus, the mean score of the BP scale in
the fibrin-sealant group clearly improved from 59.85± 18.77 pre-
operatively to 74.60± 21.09 1 year postoperatively; in contrast to
the mean score of the BP scale in the suture group, which did
not significantly improve from 66.38± 20.21 preoperatively to
66.63± 34.59 1 year postoperatively. In the fibrin-sealant group,
the mean GH score (Figure 2B) increased from 71.85± 7.98 pre-
operatively to 74.54± 13.29 6 weeks postoperatively and further
to 75.82± 11.10 6 months postoperatively. From the 6 months
level, the mean GH score decreased to 73.43± 13.34 1 year post-
operatively. In the suture group, the mean GH score immedi-
ately decreased from 70.25± 16.74 preoperatively to 69.58± 19.55
6 weeks postoperatively. Then in the period from 6 weeks to
6 months postoperatively, the mean GH score did not change sig-
nificantly to 69.68± 20.86. However, the mean GH score then
clearly decreased to its lowest level of 54.98± 28.37 1 year post-
operatively. One year postoperatively, the mean GH score of
73.43± 13.34 in the fibrin-sealant group was significantly higher
(P = 0.015) than the mean GH score of 54.98± 28.37 in the suture
group.
In the fibrin-sealant group, the mean VT score instantly raised
from 55.38± 11.82 preoperatively to 65.54± 19.97 6 weeks post-
operatively and further to 66.65± 19.15 6 months postoperatively.
Subsequently, the mean VT score in the fibrin-sealant group did
not significantly change to 66.10± 20.10 1 year postoperatively.
In contrast to the fibrin-sealant group, the mean VT score in
the suture group instantly felt from 65.31± 21.18 preoperatively
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FIGURE 2 | Differences between group in the most relevant SF-36 outcome parameters.
to 58.04± 21.96 6 weeks postoperatively. The mean VT score
then rose to 69.68± 20.86 6 months postoperatively, to finally
fall to its lowest level of 52.54± 29.54 1 year postoperatively.
The mean SF score in the fibrin-sealant group increased from
75.00± 18.19 preoperatively to 78.27± 26.61 6 weeks postopera-
tively and furthermore to 87.30± 17.63 6 months postoperatively.
From the level at 6 months postoperatively, the mean SF score
decreased to 83.82± 19.95 1 year postoperatively. In contrast to
the fibrin-sealant group, the mean SF score in the suture group
instantly decreased postoperatively from 83.59± 20.96 preop-
eratively to 78.23± 26.85 6 weeks postoperatively. Subsequently,
the mean SF score increased to 81.98± 23.79 6 months post-
operatively. However, the mean SF score then decreased again
from the level at 6 months postoperatively to 68.23± 37.95 1 year
postoperatively. In the fibrin-sealant group, the mean RE score
advanced from 69.23± 35.17 preoperatively to 85.51± 30.18
6 weeks postoperatively. Subsequently, the mean RE score in
the fibrin-sealant group did not significantly change during
the remaining follow-up period (83.66± 30.27 6 months post-
operatively and 85.51± 30.18 1 year postoperatively). In con-
trast, the mean RE score in the suture group immediately
regressed postoperatively from 75.00± 35.05 preoperatively to
70.09± 41.74 6 weeks postoperatively. The mean RE score con-
tinued to regress to 68.43± 43.90 6 months postoperatively and
further to 50.09± 46.55 1 year postoperatively. One year postop-
eratively, the mean RE score of 85.51± 30.18 in the fibrin-sealant
group was significantly higher (P = 0.08) than the mean RE score
of 50.09± 46.55 in the suture group. The mean MH score in
the fibrin-sealant group did not significantly change during the
entire follow-up. Likewise in the fibrin-sealant group, the mean
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MH score in the suture group did not significantly change in
the first 6 months postoperatively. However, the mean MH score
in the suture group then clearly decreased from 71.98± 18.08
at 6 months postoperatively to 60.78± 32.50 1 year postoper-
atively. In the fibrin-sealant group, the mean physical health
summary (PHS) score (Figure 2C) improved constantly from
43.17± 8.59 preoperatively to 49.05± 8.65 1 year postoperatively.
In contrast to the fibrin-sealant group, the mean PHS score in
the suture group deteriorated from primarily 45.27± 8.01 pre-
operatively to 43.55± 9.64 6 weeks postoperatively. The mean
PHS score then improved to 47.92± 8.56 1 year postoperatively.
However, the mean PHS score in the suture group subsequently
decreased to 41.91± 19.54 1 year postoperatively. In the fibrin-
sealant group, the mean MHS score (Figure 2D) did not sig-
nificantly change during the entire follow-up period Whereas,
the mean MHS score in the suture group decreased constantly
from 51.00± 7.79 preoperatively to 46.94± 12.18 1 year postop-
eratively.
DISCUSSION
Since the routine utilization of prosthetic meshes in inguinal
hernia surgery has become popular and because of the thereby
obtained low recurrence rates, most novel clinical trials focus on
aspects of quality of life and postoperative pain. More recently
several trials indicated that fibrin-sealant mesh fixation is supe-
rior to suture fixation on aspects of quality of life, postopera-
tive pain, and patient comfort (6, 24–27, 32). However, the data
received from these trials is still limited and therefore need further
investigations.
Besides the fixation of the mesh, the mesh itself frequently
is the focus of observation. In this study, the Inifnit® mesh by
W. L. Gore & Associates, a new monofilament, macro-porous,
knitted PTFE mesh, was used. As a result of the arbitrary with-
drawal from market of the Inifnit® mesh by W. L. Gore & Asso-
ciates without any adverse events associated with the mesh; this
study was constrained to abort prematurely. However, Inifnit®
mesh was well tolerated in all enrolled patients and low compli-
cation rates were recorded. Therefore, a monofilament, macro-
porous, and knitted PTFE mesh seems to be a practicable alterna-
tive to common standard polypropylene meshes in Lichtenstein
hernioplasty.
This study further indicates that fibrin-sealant mesh fixation
results in a higher postoperative quality of life and in significantly
less postoperative pain compared to suture mesh fixation. Though
it must be noted that the number of patients included in this
study was limited to 38 patients and therefore all statistic analy-
ses have to be evaluated with caution. Especially, the analysis of
the SF-36 questionnaire demands a higher number of patients to
obtain reliable and significant results. The results of the analysis
of the VAS scores appeared more reliable, related to the fact that
this study was powered for this endpoint. Accordingly, the dif-
ference of the postoperative pain (6 weeks, 6 months, and 1 year
postoperatively) between both groups was significant in favor of
the fibrin-sealant group. Prior to this study, the maximum differ-
ence between the parameters pain and quality of life was expected
in the early postoperative period, due to the traumatic suture fix-
ation compared to the atraumatic fibrin-sealant mesh fixation.
The maximum difference between the parameters pain and qual-
ity of life were though at the end of the follow-up in this study,
1 year postoperatively. The fact that fibrin glue is biodegradable,
biocompatible, and is replaced by connective tissue within 2 weeks
might play a major role, since non-absorbable sutures are not
biodegradable and potentially maintain a chronic inflammatory
process associated with pain and discomfort. These results were
reflected by the TIMELI trial, as in the TIMELI trial the differ-
ence of postoperative pain between both groups was significant in
favor of the fibrin-sealant group 1 and 6 months postoperatively
(32). Other surgical complications beside postoperative pain were
distributed equally among both groups in this study. The novel
composite primary study endpoint suggested in the TIMELI trial
[the incidence of at least one moderate-severe (VAS≥30) compli-
cation regarding pain and/or numbness and/or groin discomfort]
is an interesting approach to provide a combined quantitative
assessment of these parameters. Although we would propose to
summate all three values and thus, receiving an overall measure
ranging from 0 to 300. This would allow identifying the level of
impairment of the postoperative quality of life regarding pain,
numbness, and groin discomfort.
In addition to lower postoperative pain and a superior postop-
erative quality of life detected in the fibrin-sealant group, this study
demonstrates another benefit of the fibrin-sealant mesh fixation.
Namely, the accelerated surgical procedure, this study indicates
that the operation is shorter when fibrin glue instead of sutures
is used to fixate the mesh. This effect is expected to enlarge when
fibrin-sealant mesh fixation has become routine and the respective
surgeons are acquaint with the technique, since there is a learning
curve applying fibrin glue. Furthermore the mean hospital stay of
the patients assigned to the fibrin-sealant group was shorter com-
pared to the mean hospital stay of the patients in the suture group.
However, the shortened operation in the fibrin-sealant group was
not significant but other similar trials especially the TIMELI trial
did reflect this finding (32).
Among surgeons, there is always controversy about the recur-
rence rates after fibrin-sealant mesh fixation. Many surgeons fear
that the enhanced postoperative quality of life and the low post-
operative pain after fibrin-sealant mesh fixation is achieved at the
expense of the low recurrence rates known after standard suture
mesh fixation. In this study, one recurrent hernia was found in
the fibrin-sealant group and none in the suture group, though
the limited number of patients in this study that it is not possible
to draw a conclusion. Although the TIMELI trial demonstrated
very low recurrence rates for both suture and fibrin-sealant mesh
fixation (32).
Overall, the results of this study support the findings of sim-
ilar studies (6, 24–27, 32) and further underline the benefits of
fibrin-sealant mesh fixation on aspects of pain, quality of life,
the duration of the surgical procedure, and the duration of the
hospital stay.
For future trials, we suggest to choose a longer follow-up period
and a lager number of patients, to receive more reliable recurrence
rates. New questionnaires more specific for the surgical problem,
which have not been available when the study was conducted
could also be implemented in future trials (e.g., the App provided
by Carolinas Medical Center). Additionally further investigations,
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whether large medial hernias (M III, Aachen classification) are
capable for fibrin-sealant mesh fixation, have to be made since
M III hernias were excluded in this study as well as in similar
studies.
CONCLUSION
In conclusion, this study demonstrates that fibrin-sealant mesh
fixation is well tolerated and effective in reducing postopera-
tive pain and improving postoperative quality of life. Therefore,
fibrin-sealant mesh fixation represents an excellent alternative to
standard suture mesh fixation in Lichtenstein hernioplasty.
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